Singapoo - Kiingereza - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - general hospital - the colleague pumps are capable of delivering medications, solutions, parenteral nutrition, lipids, blood, and blood components. the colleague pumps are capable of infusing a variety of source containers to include semi-rigid containers, rigid containers, and flexible iv bags. the colleague pumps are designed to deliver infusion therapies via clinically acceptable routes of administration, including intravenous, intra-arterial, epidural, and subcutaneous routes. the colleague pumps are intended for use in a wide variety of patient care environments for adult, pediatric, and neonatal patients. the colleague pumps facilitate the delivery of routine and critical infusion therapies via continuous and intermittent delivery using primary and secondary infusion modes.

Singapoo - Kiingereza - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - general hospital - the colleague pumps are capable of delivering medications, solutions, parenteral nutrition, lipids, blood, and blood components. the colleague pumps are capable of infusing a variety of source containers to include semi-rigid containers, rigid containers, and flexible iv bags. the colleague pumps are designed to deliver infusion therapies via clinically acceptable routes of administration, including intravenous, intra-arterial, epidural, and subcutaneous routes. the colleague pumps are intended for use in a wide variety of patient care environments for adult, pediatric, and neonatal patients. the colleague pumps facilitate the delivery of routine and critical infusion therapies via continuous and intermittent delivery using primary and secondary infusion modes.

Israeli - Kiingereza - Ministry of Health

baxter healthcare distribution ltd., israel - sevoflurane - liquid for inhalation - sevoflurane 100 %v/v - sevoflurane - sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Filipino - Kiingereza - FDA (Food And Drug Administration)

baxter healthcare phils inc - 0.45% sodium chloride - solution for i.v. infusion

Filipino - Kiingereza - FDA (Food And Drug Administration)

baxter healthcare phils inc - dextrose in water - solution for iv infusion - 0.1

Filipino - Kiingereza - FDA (Food And Drug Administration)

baxter healthcare phils inc - dopamine hydrochloride - dextrose injection - 400mg/250ml (1.6mg/ml)

Filipino - Kiingereza - FDA (Food And Drug Administration)

baxter healthcare phils inc - hemodialysis concentrate - solution for hemodialysis

Filipino - Kiingereza - FDA (Food And Drug Administration)

baxter healthcare phils inc - hemodialysis concentrate - solution for hemodialysis

Filipino - Kiingereza - FDA (Food And Drug Administration)

baxter healthcare phils., inc. - peritoneal dialysis solution with 4.25% dextrose - solution for intraperitoneal administration (dialysis) - 0.0425

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - fluconazole, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - fluconazole-baxter intravenous infusion should be used only when fluconazole cannot be administered orally: 1. treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note: data suggest that the clinical efficacy of fluconazole is lower than that of amphotericin b in the treatment of the acute phase of cryptococcal meningitis. 2. maintenance therapy to prevent relapse of cryptococcal meningitis in patients with acquired immune deficiency syndrome (aids). 3. treatment of oropharyngeal and oesophageal candidiasis in patients with aids and other immunosuppressed patients. 4. secondary prophylaxis of oropharyngeal candidiasis in patients with human immunodeficiency virus (hiv) infection. 5. vaginal candidiasis, when topical therapy has failed. 6. serious and life-threatening candida infections in patients who are unable to tolerate amphotericin b. note: it remains to be shown that fluconazole is as effective as amphotericin b in the treatment of serious and life-threatening candida infections. until such data are available, amphotericin b remains the drug of choice.